Navigation Links
First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping
Date:3/16/2009

WASHINGTON, DCGenetic researchers at Children's National Medical Center and the National Center of Neurology and Psychiatry in Tokyo published the results of the first successful application of "multiple exon-skipping" to curb the devastating effects of Duchenne muscular dystrophy in an animal larger than a mouse. Multiple exon-skipping employs multiple DNA-like molecules as a "DNA band-aids" to skip over the parts of the mutated gene that block the effective creation of proteins.

The study, conducted in Japan and the United States, published this month in the peer-reviewed journal of the American Neurological Association, the Annals of Neurology, treated dogs with naturally occurring canine X-linked muscular dystrophy, a disease which is genetically homologous to the Duchenne muscular dystrophy that strikes 1 of every 3,500 boys born in the United States and worldwide each year.

Duchenne muscular dystrophy, one of the most common lethal genetic disorders, is an X-linked genetic mutation that causes an inability of the body's cells to effectively create dystrophinwhich builds muscle tissue. "Exon-skipping" employs synthetic DNA-like molecules called antisense as a DNA band-aid to skip over the parts of the gene that block the effective creation of dystrophin. Because the gene's mutation could affect any of its 79 exons and sometimes more than one single exon at a time, scientists employed a "cocktail" of antisense called morpholinos to extend the range of this application. By skipping more than a single exon, this so-called DNA band-aid becomes applicable to between 80 and 90 percent of Duchenne muscular dystrophy patients, including the mutation found in dogs.

"This trial makes the much-talked about promise of exon-skipping as a systemic treatment for Duchenne muscular dystrophy in humans a real possibility in the near term," said Toshifumi Yokota, PhD, lead author of the study. "Of course this success has also introduced even more avenues for investigation, but these findings finally overcome a significant hurdle to our progresswe've solved the riddle of an effective system-wide delivery to muscle tissue, and seen promising results."

A new state-of-the-art facility at the National Center of Neurology and Psychiatry in Japan was utilized to carry out the research.

"This study delivers the proof-of-concept that systemic anti-sense therapy can be done in a large organism, in Duchenne muscular dystrophy or any disease", says Eric Hoffman, PhD, a senior author of the study and director of the Center for Genetic Medicine at Children's National Medical Center.

"Systemic treatment of the majority of Duchenne dystrophy will require multiple sequences to be delivered in the blood, and this study also is the first proof-of-principle of multiple exon-skipping in any organism," Shin'ichi Takeda, MD, another senior author, said. "In order to realize that promise in human trials, it also will be important to re-evaluate current measures of toxicity, efficacy, and marketing that ensure both safety for the patient, as well as rapid development and distribution of life-saving drugs.

The authors do note that significant steps still remain. Successful systemic treatment with morpholinos requires large doses of the antisense moleculesand the technology is costly and difficult to obtain. Additionally, treatment in this study showed diminished success at curbing muscle deterioration of the heart, meaning that a more effective and specific delivery system is needed to rescue the organ's delicate tissue in Duchenne muscular dystrophy patients. However, these early successes do show much promise for the oft-discussed exon-skipping method as an effective treatment for Duchenne muscular dystrophy and some other genetic disorders.


'/>"/>

Contact: Jennifer Leischer
jleische@cnmc.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Related medicine news :

1. Expresso Fitness(R) Launches First Virtual Reality Cardio Bike for Kids
2. ABMS Hosts First National Health Policy Forum to Address Physician Accountability and Health System Performance Standards
3. Young Onset Parkinson Conferences: A First-Ever Collaboration
4. First DHI-Licensed Door Inspection Software Solution Ships to DOORDATA Solutions' Charter Members
5. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
6. Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009
7. First Rewards Paid to New Jersey Doctors Through Participation in Bridges to Excellence
8. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
9. BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
10. Yankees Will Become First MLB Team to Integrate Highly Advanced Antimicrobial System
11. Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical ... 2017 who are passionate about making a difference in the lives of the ... Tampa, UMA, a nonprofit healthcare educational institution, has more than 30,000 alumni and ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Sam & ... assistance to commercial and residential clients in the California Bay Area, is launching a ... health in the region. , Heart disease is the primary killer of adult men ...
(Date:1/19/2017)... ... ... Tribble Insurance Agency, a family owned and operated firm offering asset protection and ... honor Chad Phillip Dermyer, a local police trooper who was shot and killed serving ... officers were conducting routine stops of suspects when one of them, a violent career ...
(Date:1/19/2017)... ... , ... St. Catherine’s Village announced that a limited number of rooms have ... on the grounds of the St. Catherine’s Village campus in Madison, Mississippi that accommodates ... home in Mississippi for the second year in a row by readers of the ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... taken in the 2017 Spring Create Real Impact contest from Impact Teen Drivers ... 17 at http://www.createrealimpact.com . , Educational grants totaling $15,000 will be ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... LONDON , Jan. 18, 2017 ... 2022 Summary GlobalData,s new report, "South Korea ... data on the South Korea Insulin Delivery market. The ... (in units) and average prices (USD) within market segments ... Insulin Pump Accessories. The report also provides company ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 ... "Breast Imaging Technologies Market by Type: Global Opportunity Analysis and ... market size was valued at $2,544 million in 2015 and ... a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in 2015. Ionizing ...
(Date:1/18/2017)... Calif. , Jan. 18, 2017  Adaptive Sound Technologies, ... today a new partnership with Hyatt Place Nashville/Downtown to ... providing ASTI LectroFan sleep therapy machines in over two ... of the most important parts of having a great ... general manager of Hyatt Place Nashville/Downtown. "We,re pleased to ...
Breaking Medicine Technology: